621
Views
95
CrossRef citations to date
0
Altmetric
Articles

A systematic review of treatment fatigue among HIV-infected patients prescribed antiretroviral therapy

, , &
Pages 255-265 | Received 29 Jan 2014, Accepted 07 Jul 2014, Published online: 11 Aug 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (11)

Daisy Ramirez-Ortiz, Sofia B. Fernandez, Michele Jean-Gilles, Annette Flores, Taidiana Gonzalez Santander, Rahel Dawit, Cynthia Ibarra, Melissa K. Ward, Petra Brock, Robert Ladner, Jessy Dévieux & Mary Jo Trepka. (2023) Barriers and facilitators to retention in care and treatment adherence among racially/ethnically diverse women with HIV in South Florida: a qualitative study. Women & Health 63:7, pages 562-576.
Read now
Jordan M. Sang, Zishan Cui, Lu Wang, Nicanor Bacani, Nathan J. Lachowsky, Allan Lal, Kiffer G. Card, Eric A. Roth, Julio S. G. Montaner, Terry Howard, Robert S. Hogg & David M. Moore. (2023) Treatment interruptions and community connectedness among gbMSM living with HIV in Metro Vancouver, Canada. AIDS Care 35:1, pages 139-147.
Read now
Daniel Chemtob, Itzchak Levy, Shai Kaufman, Nechama Averick, Agate Krauss & Dan Turner. (2022) Drop-out of medical follow-up among people living with HIV in Tel-Aviv area. AIDS Care 34:5, pages 621-625.
Read now
Quan Zhang, Xiaoming Li, Shan Qiao, Shuaifeng Liu, Zhiyong Shen & Yuejiao Zhou. (2021) Association between hair cortisol, hair cortisone, and fatigue in people living with HIV. Stress 24:6, pages 772-779.
Read now
Luh Putu Lila Wulandari, I Made Adimantara, Ni Made Sri Nopiyani & Ni Wayan Septarini. (2020) Understanding why people who inject drugs in Indonesia are disengaged from HIV testing and treatment: gaps in the HIV treatment cascade. Journal of Substance Use 25:4, pages 398-404.
Read now
J. Jaiswal, M. D. Francis, S. N. Singer, K. B. Dunlap, A. B. Cox & R. Greene. (2020) “Worn out”: Coping strategies for managing antiretroviral treatment fatigue among urban people of color living with HIV who were recently disengaged from outpatient HIV care. Journal of HIV/AIDS & Social Services 19:2, pages 173-187.
Read now
Cosmina Gingaras, Colette Smith, Roxana Radoi, Diana Sima, Mike Youle & Luminita Ene. (2019) Engagement in care among youth living with parenterally-acquired HIV infection in Romania. AIDS Care 31:10, pages 1290-1296.
Read now
Margaret Nyaku, Linda Beer & Fengjue Shu. (2019) Non-persistence to antiretroviral therapy among adults receiving HIV medical care in the United States. AIDS Care 31:5, pages 599-608.
Read now
Munyaradzi Madhombiro, Bazondlile Marimbe-Dube, Michelle Dube, Malinda Kaiyo-Utete, Angeline Paradzai, Dixon Chibanda, Simbarashe Rusakaniko, ASJ van der Watt & Soraya Seedat. (2018) Perceptions of alcohol use in the context of HIV treatment: a qualitative study. HIV/AIDS - Research and Palliative Care 10, pages 47-55.
Read now
Elizabeth Yang, Seipone Mphele, Neo Moshashane, Boineelo Bula, Jennifer Chapman, Harriet Okatch, Ed Pettitt, Ontibile Tshume, Tafireyi Marukutira, Gabriel Anabwani & Elizabeth Lowenthal. (2018) Distinctive barriers to antiretroviral therapy adherence among non-adherent adolescents living with HIV in Botswana. AIDS Care 30:2, pages 224-231.
Read now

Articles from other publishers (84)

Cointa Arroyo-Jiménez, Corina Benjet, Rebeca Robles, Nancy Patricia Caballero-Suárez, Carmen Lizette Gálvez-Hernández, Javier Ordoñez-Ortega, Marco Tulio Suárez-Maldonado & Luis Xochihua. (2023) Social and mental health characteristics of adolescents living with HIV in Mexico: Implications for adherence to Antiretroviral Treatment. Journal of Health Psychology.
Crossref
Douglas Barthold, Enrique M. Saldarriaga, Aaron T. Brah, Brett Hauber, Pallavi Banerjee, Shanil M. Fuller, Divine McCaslin, Ana Maria Moldoveanu, Vincent C. Marconi, Jane M. Simoni & Susan M. Graham. (2023) Preference for daily oral pills over long-acting antiretroviral therapy options among people with HIV. AIDS 37:10, pages 1545-1553.
Crossref
Wenjing Wang, Shengnan Zhao, Yaxin Wu, Wenshan Duan, Sibo Li, Zhen Li, Caiping Guo, Wen Wang, Tong Zhang, Hao Wu & Xiaojie Huang. (2023) Safety and Efficacy of Long-Acting Injectable Agents for HIV-1: Systematic Review and Meta-Analysis. JMIR Public Health and Surveillance 9, pages e46767.
Crossref
Susan M. Graham, Douglas Barthold, Brett Hauber, Aaron T. Brah, Enrique Saldarriaga, Ann C. Collier, Rodney J. Y. Ho, Vincent C. Marconi & Jane M. Simoni. (2023) U.S. patient preferences for long‐acting HIV treatment: a discrete choice experiment. Journal of the International AIDS Society 26:S2.
Crossref
Ming Guan & Hongyi Guan. (2023) Associations between treatment burden, self-reported treatment qualities, antiretroviral therapy obtainment, and health-related quality of life among Ugandan PLWH. Cost Effectiveness and Resource Allocation 21:1.
Crossref
Patricia A. Cioe, Alexander W. Sokolovsky, Judson A. Brewer & Christopher W. Kahler. (2023) App-Delivered Mindfulness Training to Reduce Anxiety in People with HIV Who Smoke: A One-Armed Feasibility Trial. International Journal of Environmental Research and Public Health 20:6, pages 4826.
Crossref
Samir K Gupta, Mezgebe Berhe, Gordon Crofoot, Paul Benson, Moti Ramgopal, James Sims, Cheryl McDonald, Peter Ruane, William E Sanchez, Anita Scribner, Shan-Yu Liu, Laurie A VanderVeen, Hadas Dvory-Sobol, Martin S Rhee, Jared M Baeten & Ellen Koenig. (2023) Lenacapavir administered every 26 weeks or daily in combination with oral daily antiretroviral therapy for initial treatment of HIV: a randomised, open-label, active-controlled, phase 2 trial. The Lancet HIV 10:1, pages e15-e23.
Crossref
Tali Cassidy, Morna Cornell, Bubele Makeleni, C. Robert Horsburgh, Laura Trivino Duran, Virginia de Azevedo, Andrew Boulle & Matthew P. Fox. (2022) Attrition from Care Among Men Initiating ART in Male-Only Clinics Compared with Men in General Primary Healthcare Clinics in Khayelitsha, South Africa: A Matched Propensity Score Analysis. AIDS and Behavior 27:1, pages 358-369.
Crossref
Philomena J. Strother, Mathuros Tipayamongkholgul, Varakorn Kosaisevee & Nawarat Suwannapong. (2022) Effects of psychosocial factors on nonadherence to ART in Ganta, Nimba county, Liberia. AIDS Research and Therapy 19:1.
Crossref
Uzaib Saya, Sarah MacCarthy, Barbara Mukasa, Peter Wabukala, Lillian Lunkuse, Zachary Wagner & Sebastian Linnemayr. (2022) “The one who doesn’t take ART medication has no wealth at all and no purpose on Earth” – a qualitative assessment of how HIV-positive adults in Uganda understand the health and wealth-related benefits of ART. BMC Public Health 22:1.
Crossref
Kelly Richardson, Jessica E. Huber, Brianna Kiefer & Sandy Snyder. (2022) Perception of Physical Demand, Mental Demand, and Performance: A Comparison of Two Voice Interventions for Parkinson's Disease. American Journal of Speech-Language Pathology 31:5, pages 1963-1978.
Crossref
Ekaterina N. Ozhmegova & Marina R. Bobkova. (2022) HIV drug resistance: past and current trends. Problems of Virology 67:3, pages 193-205.
Crossref
Tiffany Chenneville, Hunter Drake, Alexandra Cario & Carina Rodriguez. (2022) Adverse Childhood Experiences among a Sample of Youth Living with HIV in the Deep South. International Journal of Environmental Research and Public Health 19:15, pages 9740.
Crossref
Sofia Stover, M.-J. Milloy, Cameron Grant, Nadia Fairbairn & M. Eugenia Socías. (2022) Estimating the minimum antiretroviral adherence required for plasma HIV-1 RNA viral load suppression among people living with HIV who use unregulated drugs. AIDS 36:9, pages 1233-1243.
Crossref
Jessica El Halabi, William Minteer & Kasey R. Boehmer. (2022) Identifying and Managing Treatment Nonadherence. Medical Clinics of North America 106:4, pages 615-626.
Crossref
Brooke W. Bullington, Andrew Edmonds, Catalina Ramirez, Lisa Rahangdale, Genevieve Neal-Perry, Deborah Konkle-Parker, Deborah Jones Weiss, Caitlin Moran, Elizabeth Topper Golub, Helen Cejtin, Dominika Seidman, Seble Kassaye, Tracey E. Wilson, Anjali SharmaAdaora A. Adimora & Andrea K. Knittel. (2022) Premature and early menopause among US women with or at risk for HIV. Menopause 29:6, pages 741-747.
Crossref
Morgan M. Philbin, Sadie Bergen, Carrigan Parish, Deanna Kerrigan, Elizabeth N. Kinnard, Sarah Reed, Mardge H. Cohen, Oluwakemi Sosanya, Anandi N. Sheth, Adaora A. Adimora, Jennifer Cocohoba, Lakshmi Goparaju, Elizabeth T. Golub, Michael Vaughn, José I. GutierrezJr.Jr., Margaret A. Fischl, Maria Alcaide & Lisa R. Metsch. (2021) Long-Acting Injectable ART and PrEP Among Women in Six Cities Across the United States: A Qualitative Analysis of Who Would Benefit the Most. AIDS and Behavior 26:4, pages 1260-1269.
Crossref
Amie Koch, Tiarney D. Ritchwood, Donald E. Bailey, Courtney Ellis Caiola, Adaora A. Adimora, Catalina Ramirez, Lauren Holt, Ragan Johnson, Kara McGee, Jacquelyn M. McMillian-Bohler, Schenita D. Randolph & Michael V. Relf. (2022) Exploring Resilience Among Black Women Living With HIV in the Southern United States: Findings From a Qualitative Study. Journal of the Association of Nurses in AIDS Care 33:2, pages 224-234.
Crossref
Emilia M. Jalil, Thiago S. Torres, Paula M. Luz, Laylla Monteiro, Ronaldo I. Moreira, Cristiane R. V. de Castro, Iuri da C. Leite, Marcello Cunha, Rita de Cássia Elias Estrela, Michelle Ramos, Brenda Hoagland, Sandra Wagner Cardoso, Peter Anderson, Valdilea G. Veloso, Erin Wilson & Beatriz Grinsztejn. (2022) Low PrEP adherence despite high retention among transgender women in Brazil: the PrEParadas study. Journal of the International AIDS Society 25:3.
Crossref
Connor P. Bondarchuk, Nwabisa Mlandu, Tasneem Adams & Elma de Vries. (2022) Predictors of low antiretroviral adherence at an urban South African clinic: A mixed-methods study. Southern African Journal of HIV Medicine 23:1.
Crossref
Margaret M. Paschen-Wolff, Aimee N. C. Campbell, Susan Tross, Tse-Hwei Choo, Martina Pavlicova, Sarah Braunstein, Rachael Lazar, Christine Borges, Michael Castro, Hayley Berg, Graham Harriman, Robert H. Remien & Don Des Jarlais. (2021) Durable Viral Suppression Among People with HIV and Problem Substance Use in the Era of Universal Antiretroviral Treatment. AIDS and Behavior 26:2, pages 385-396.
Crossref
Alejandro J. Paredes, Fabiana Volpe-Zanutto, Lalitkumar K. Vora, Ismaiel A. Tekko, Andi Dian Permana, Camila J. Picco, Helen O. McCarthy & Ryan F. Donnelly. (2022) Systemic delivery of tenofovir alafenamide using dissolving and implantable microneedle patches. Materials Today Bio 13, pages 100217.
Crossref
Edwin Nuwagira, Boniface A. E. Lumori, Rose Muhindo, Michael Kanyesigye, Abdallah Amir, Winnie Muyindike & Conrad Muzoora. (2021) Incidence and predictors of early loss to follow up among patients initiated on protease inhibitor-based second-line antiretroviral therapy in southwestern Uganda. AIDS Research and Therapy 18:1.
Crossref
Abd Moain Abu Dabrh, Kasey R. Boehmer, Nathan Shippee, Stacey A. Rizza, Adam I. Perlman, Sara R. Dick, Emma M. Behnken & Victor M. Montori. (2021) Minimally disruptive medicine (MDM) in clinical practice: a qualitative case study of the human immunodeficiency virus (HIV) clinic care model. BMC Health Services Research 21:1.
Crossref
Zhongfang Yang, Zheng Zhu, Lucylynn Lizarondo, Weijie Xing, Shuyu Han, Hui Hu, Yan Hu & Bei Wu. (2021) Experience of chronic noncommunicable disease in people living with HIV: a systematic review and meta-aggregation of qualitative studies. BMC Public Health 21:1.
Crossref
Carolyn A Fahey, Prosper F Njau, Nicole K Kelly, Rashid S Mfaume, Patrick T Bradshaw, William H Dow & Sandra I McCoy. (2021) Durability of effects from short-term economic incentives for clinic attendance among HIV positive adults in Tanzania: long-term follow-up of a randomised controlled trial. BMJ Global Health 6:12, pages e007248.
Crossref
Sudeep Gupta, Ghanashyam Biswas, Suresh Babu, Tanveer M. Maksud, Kuntegowdennahalli C. Lakshmaiah, Jayanti G. Patel, Gopal Raja, Rakesh R. Boya, Pramod Patil, Kakali Choudhury, Shailesh A. Bondarde, Rakesh S. Neve, Guruprasad Bhat, Gopichand Mamillapalli, Apurva A. Patel, Piyush Patel, Nisarg Joshi, Vinay Bajaj & Mujtaba A. Khan. (2021) Fixed dose combination of capecitabine and cyclophosphamide in metastatic breast cancer: Results from THE ENCLOSE phase 2/3 randomized multicenter study. The Breast 60, pages 147-154.
Crossref
Wendy Ankrom, Deanne Jackson Rudd, Andrea Schaeffer, Deborah Panebianco, Evan J. Friedman, Charles Tomek, S. Aubrey Stoch & Marian Iwamoto. (2021) Pharmacokinetic and Safety Profile of the Novel HIV Nonnucleoside Reverse Transcriptase Inhibitor MK-8507 in Adults without HIV. Antimicrobial Agents and Chemotherapy 65:12.
Crossref
Hans Jaeger, Edgar T Overton, Gary Richmond, Giuliano Rizzardini, Jaime Federico Andrade-Villanueva, Rosie Mngqibisa, Antonio Ocampo Hermida, Anders Thalme, Elena Belonosova, Faïza Ajana, Paul D Benn, Yuanyuan Wang, Krischan J Hudson, Carlos Martín Español, Susan L Ford, Herta Crauwels, David A Margolis, Christine L Talarico, Kimberly Y Smith, Veerle van Eygen, Rodica Van Solingen-Ristea, Simon Vanveggel & William R Spreen. (2021) Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 96-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study. The Lancet HIV 8:11, pages e679-e689.
Crossref
Vaibhav Penukonda, Timothy Utz, Nicholas S. Perry, Deanna Ware, Mark Brennan-Ing, Steven Meanley, Andre Brown, Sabina Haberlen, James Egan, Steven Shoptaw, Linda A. Teplin, M. Reuel Friedman & Michael Plankey. (2021) Viral suppression among middle-aged and aging MSM living with HIV: Partnership type and quality. PLOS ONE 16:10, pages e0258032.
Crossref
Tariro D. Chawana, Charles F. B. Nhachi, Kusum Nathoo, Bernard Ngara, Hideaki Okochi, Alexander Louie, Karen Kuncze, David Katzenstein, John Metcalfe & Monica Gandhi. (2021) Brief Report: Ritonavir Concentrations in Hair Predict Virologic Outcomes in HIV-Infected Adolescents With Virologic Failure on Atazanavir-Based or Ritonavir-Based Second-Line Treatment. JAIDS Journal of Acquired Immune Deficiency Syndromes 88:2, pages 181-185.
Crossref
Ronald J. Hazen, Drew Halbur, Brittany Mills, Heather S. Kirkham & John Hou. (2021) Evaluation of Medication Therapy Issues, Resolutions, and Adherence Among Persons With HIV in the Pharmacist-Led Patient-Centered HIV Care Model. JAIDS Journal of Acquired Immune Deficiency Syndromes 88:1, pages 96-102.
Crossref
Chibueze Anosike, Chigozie G. Anene-Okeke & Maureen O. Akunne. (2021) Assessment of Health-Related Quality of Life Among Patients Infected With HIV Receiving Care in a Nigerian Tertiary Hospital. Value in Health Regional Issues 25, pages 1-6.
Crossref
Alejandro J. Paredes, Fabiana Volpe-Zanutto, Andi Dian Permana, Aidan J. Murphy, Camila J. Picco, Lalitkumar K. Vora, Jonathan A. Coulter & Ryan F. Donnelly. (2021) Novel tip-loaded dissolving and implantable microneedle array patches for sustained release of finasteride. International Journal of Pharmaceutics 606, pages 120885.
Crossref
Yihalem Abebe Belay, Mezgebu Yitayal, Asmamaw Atnafu & Fitalew Agimass Taye. (2021) Patients’ preferences for antiretroviral therapy service provision: a systematic review. Cost Effectiveness and Resource Allocation 19:1.
Crossref
Zhengqin Gao, Rui Fu, Xiaobo Li, Ji Wang & Yuxian He. (2021) Safety Assessment of Microbicide 2P23 on the Rectal and Vaginal Microbiota and Its Antiviral Activity on HIV Infection. Frontiers in Immunology 12.
Crossref
Jordan J. McGing, Shellie Jean Radford, Susan T. Francis, Sébastien Serres, Paul L. Greenhaff & Gordon W. Moran. (2021) Review article: The aetiology of fatigue in inflammatory bowel disease and potential therapeutic management strategies. Alimentary Pharmacology & Therapeutics 54:4, pages 368-387.
Crossref
Patricia de los Rios, Chinyere Okoli, Erika Castellanos, Brent Allan, Benjamin Young, Garry Brough, Marvelous Muchenje, Anton Eremin, Giulio Maria Corbelli, Marta McBritton, W. David Hardy & Nicolas Van de Velde. (2020) Physical, Emotional, and Psychosocial Challenges Associated with Daily Dosing of HIV Medications and Their Impact on Indicators of Quality of Life: Findings from the Positive Perspectives Study. AIDS and Behavior 25:3, pages 961-972.
Crossref
Rajpushpa Labh & Rachna Gupta. (2021) Emerging Trends in the Long-Acting Antiretroviral Therapy: Current Status and Therapeutic Challenges. Current HIV Research 19:1, pages 4-13.
Crossref
Kimberly K. Scarsi & Susan Swindells. (2021) The Promise of Improved Adherence With Long-Acting Antiretroviral Therapy: What Are the Data?. Journal of the International Association of Providers of AIDS Care (JIAPAC) 20, pages 232595822110090.
Crossref
Kyle Gordon, Risa M. Hoffman, Gulrez Azhar, Daniel Ramirez, Stefan Schneider & Glenn J. Wagner. (2020) Examining Correlates of Pre-ART and Early ART Adherence to Identify Key Factors Influencing Adherence Readiness. AIDS and Behavior 25:1, pages 113-123.
Crossref
Sebastian Linnemayr, Chad Stecher, Uzaib Saya, Sarah MacCarthy, Zachary Wagner, Larissa Jennings & Barbara Mukasa. (2020) Behavioral Economics Incentives to Support HIV Treatment Adherence (BEST): Protocol for a randomized controlled trial in Uganda. Trials 21:1.
Crossref
Jørn Henrik Vold, Rolf Gjestad, Christer F. Aas, Fatemeh Chalabianloo, Svetlana Skurtveit, Else-Marie Løberg, Kjell Arne Johansson & Lars Thore Fadnes. (2020) Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020. Substance Abuse Treatment, Prevention, and Policy 15:1.
Crossref
Edgar T Overton, Gary Richmond, Giuliano Rizzardini, Hans Jaeger, Catherine Orrell, Firaya Nagimova, Fritz Bredeek, Miguel García Deltoro, Susan Swindells, Jaime Federico Andrade-Villanueva, Alexander Wong, Marie-Aude Khuong-Josses, Rodica Van Solingen-Ristea, Veerle van Eygen, Herta Crauwels, Susan Ford, Christine Talarico, Paul Benn, Yuanyuan Wang, Krischan J Hudson, Vasiliki Chounta, Amy Cutrell, Parul Patel, Mark Shaefer, David A Margolis, Kimberly Y Smith, Simon Vanveggel & William Spreen. (2020) Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study. The Lancet 396:10267, pages 1994-2005.
Crossref
Morgan M. Philbin, Carrigan L. Parish, Elizabeth N. Kinnard, Sarah E. Reed, Deanna Kerrigan, Maria L. Alcaide, Mardge H. Cohen, Oluwakemi Sosanya, Anandi N. Sheth, Adaora A. Adimora, Jennifer Cocohoba, Lakshmi Goparaju, Elizabeth T. Golub, Margaret Fischl & Lisa R. Metsch. (2020) Multisite Study of Women Living With HIV's Perceived Barriers to, and Interest in, Long-Acting Injectable Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes 84:3, pages 263-270.
Crossref
David E Conroy, Chih-Hsiang Yang, Stephanie T Lanza, Joshua M Smyth & Constantino M Lagoa. (2020) Temporal Dynamics of Treatment Receipt in a Text Message Intervention for Physical Activity: Single-Group, Within-Person Trial. JMIR mHealth and uHealth 8:4, pages e14270.
Crossref
David E. Koren, Volodymyra Fedkiv, Huaqing Zhao, Geena Kludjian, Robert L. Bettiker, Ellen Tedaldi & Rafik Samuel. (2020) Perceptions of Long-Acting Injectable Antiretroviral Treatment Regimens in a United States Urban Academic Medical Center. Journal of the International Association of Providers of AIDS Care (JIAPAC) 19, pages 232595822098126.
Crossref
Reshma Shah, Julie Watson & Caroline Free. (2019) A systematic review and meta-analysis in the effectiveness of mobile phone interventions used to improve adherence to antiretroviral therapy in HIV infection. BMC Public Health 19:1.
Crossref
Julie Lauffenburger, Trisha Acri & Robert Gross. 2019. Pharmacoepidemiology. Pharmacoepidemiology 991 1009 .
Kathy K. Byrd, John G. Hou, Ron Hazen, Heather Kirkham, Sumihiro Suzuki, Patrick G. Clay, Tim Bush, Nasima M. Camp, Paul J. Weidle & Ambrose Delpino. (2019) Antiretroviral Adherence Level Necessary for HIV Viral Suppression Using Real-World Data. JAIDS Journal of Acquired Immune Deficiency Syndromes 82:3, pages 245-251.
Crossref
Rajith K.R. Rajoli, Charles Flexner, Justin Chiong, Andrew Owen, Ryan F. Donnelly, Eneko Larrañeta & Marco Siccardi. (2019) Modelling the intradermal delivery of microneedle array patches for long-acting antiretrovirals using PBPK. European Journal of Pharmaceutics and Biopharmaceutics 144, pages 101-109.
Crossref
Russell Brewer, Rodal Issema, Mary Moore, Sarah Chrestman, Snigdha Mukherjee, Michelle Odlum & John A. Schneider. (2019) Correlates of Durable Viral Suppression (DVS) Among Criminal Justice-involved (CJI) Black Men Living with HIV in Louisiana. AIDS and Behavior 23:11, pages 2980-2991.
Crossref
A Borghetti, D Moschese, A Cingolani, G Baldin, D Speziale, A Ciccullo, F Lombardi, A Emiliozzi, S Belmonti, A Antinori, R Cauda & S Di Giambenedetto. (2019) Lamivudine‐based maintenance antiretroviral therapies in patients living with HIV ‐1 with suppressed HIV RNA : derivation of a predictive score for virological failure . HIV Medicine 20:9, pages 624-627.
Crossref
Colin Kunzweiler, Nina Kishore, Betsey John, Kathleen Roosevelt, Sophie Lewis, R. Monina Klevens, Monica Morrison, Liisa M. Randall & Alfred DeMaria. (2019) Using HIV Surveillance and Clinic Data to Optimize Data to Care Efforts in Community Health Centers in Massachusetts: The Massachusetts Partnerships for Care Project. JAIDS Journal of Acquired Immune Deficiency Syndromes 82:1, pages S33-S41.
Crossref
Stephen R. Yant, Andrew Mulato, Derek Hansen, Winston C. Tse, Anita Niedziela-Majka, Jennifer R. Zhang, George J. Stepan, Debi Jin, Melanie H. Wong, Jill M. Perreira, Eric Singer, Giuseppe A. Papalia, Eric Y. Hu, Jim Zheng, Bing Lu, Scott D. Schroeder, Kevin Chou, Shekeba Ahmadyar, Albert Liclican, Helen Yu, Nikolai Novikov, Eric Paoli, Daniel Gonik, Renee R. Ram, Magdeleine Hung, William M. McDougall, Abraham L. Brass, Wesley I. Sundquist, Tomas Cihlar & John O. Link. (2019) A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse model. Nature Medicine 25:9, pages 1377-1384.
Crossref
Rosemarie A. Martin, Damaris J. Rohsenow & Jennifer W. Tidey. (2019) Smokers with opioid use disorder may have worse drug use outcomes after varenicline than nicotine replacement. Journal of Substance Abuse Treatment 104, pages 22-27.
Crossref
Mobolanle Balogun, Seema Thakore Meloni, Ugonnaya Ugochinyere Igwilo, Alero Roberts, Ifeoma Okafor, Adekemi Sekoni, Folasade Ogunsola, Phyllis J. Kanki & Sulaimon Akanmu. (2019) Status of HIV-infected patients classified as lost to follow up from a large antiretroviral program in southwest Nigeria. PLOS ONE 14:7, pages e0219903.
Crossref
Ingrid Eshun-Wilson, Anke Rohwer, Lynn Hendricks, Sandy Oliver & Paul Garner. (2019) Being HIV positive and staying on antiretroviral therapy in Africa: A qualitative systematic review and theoretical model. PLOS ONE 14:1, pages e0210408.
Crossref
ArjunahalliEswarachar Paramesha & LeenaKunnath Chacko. (2019) Predictors of adherence to antiretroviral therapy among PLHIV. Indian Journal of Public Health 63:4, pages 367.
Crossref
Christine Tagliaferri Rael, Michelle Martinez, Rebecca Giguere, Walter Bockting, Caitlin MacCrate, Will Mellman, Pablo Valente, George J. Greene, Susan Sherman, Katherine H. A. Footer, Richard T. D’Aquila & Alex Carballo-Diéguez. (2018) Barriers and Facilitators to Oral PrEP Use Among Transgender Women in New York City. AIDS and Behavior 22:11, pages 3627-3636.
Crossref
Cynthia B. Sinha, Nitya Bakshi, Diana Ross & Lakshmanan Krishnamurti. (2018) From trust to skepticism: An in-depth analysis across age groups of adults with sickle cell disease on their perspectives regarding hydroxyurea. PLOS ONE 13:6, pages e0199375.
Crossref
Kasey R Claborn, Ellen Meier, Mary Beth Miller, Eleanor L Leavens, Emma I Brett & Thad Leffingwell. (2018) Improving adoption and acceptability of digital health interventions for HIV disease management: a qualitative study. Translational Behavioral Medicine 8:2, pages 268-279.
Crossref
Linlin Lindayani, Yen-Chin Chen, Jung-Der Wang & Nai-Ying Ko. (2018) Complex Problems, Care Demands, and Quality of Life Among People Living With HIV in the Antiretroviral Era in Indonesia. Journal of the Association of Nurses in AIDS Care 29:2, pages 300-309.
Crossref
Biljana Cvetkovski, Vicky Kritikos, Kwok Yan & Sinthia Bosnic-Anticevich. (2018) Tell me about your hay fever: a qualitative investigation of allergic rhinitis management from the perspective of the patient. npj Primary Care Respiratory Medicine 28:1.
Crossref
Terusha Chetty, Marie‐Louise Newell, Claire Thorne & Anna Coutsoudis. (2017) Viraemia before, during and after pregnancy in HIV ‐infected women on antiretroviral therapy in rural KwaZulu‐Natal, South Africa, 2010–2015 . Tropical Medicine & International Health 23:1, pages 79-91.
Crossref
Martha E. Lang & Chloe E. Bird. 2018. Change and Maintaining Change. Change and Maintaining Change 127 165 .
Naunihal S. Virdi. 2018. Drug Adherence in Hypertension and Cardiovascular Protection. Drug Adherence in Hypertension and Cardiovascular Protection 87 97 .
Marianne Harris, Bruce Ganase, Birgit Watson, P. Richard Harrigan, Julio S. G. Montaner & Mark W. Hull. (2017) HIV treatment simplification to elvitegravir/cobicistat/emtricitabine/tenofovir disproxil fumarate (E/C/F/TDF) plus darunavir: a pharmacokinetic study. AIDS Research and Therapy 14:1.
Crossref
Alula M. Teklu & Kesetebirhan D. Yirdaw. (2017) Patients who restart antiretroviral medication after interruption remain at high risk of unfavorable outcomes in Ethiopia. BMC Health Services Research 17:1.
Crossref
D.L. Dahourou & V. Leroy. (2017) Challenges and perspectives of compliance with pediatric antiretroviral therapy in Sub-Saharan Africa. Médecine et Maladies Infectieuses 47:8, pages 511-518.
Crossref
Kathy K. Byrd, Tim Bush & Lytt I. Gardner. (2017) Do Persons Living with HIV Continue to Fill Prescriptions for Antiretroviral Drugs during a Gap in Care? Analysis of a Large Commercial Claims Database. Journal of the International Association of Providers of AIDS Care (JIAPAC) 16:6, pages 632-638.
Crossref
Jeannette F Raymond, Amelia Bucek, Curtis Dolezal, Patricia Warne, Stephanie Benson, Elaine J Abrams, Katherine S. Elkington, Seth Kalichman, Moira Kalichman & Claude A Mellins. (2017) Use of Unannounced Telephone Pill Counts to Measure Medication Adherence Among Adolescents and Young Adults Living With Perinatal HIV Infection. Journal of Pediatric Psychology 42:9, pages 1006-1015.
Crossref
Jane N Wanyama, Sharon Tsui, Cynthia Kwok, Rhoda K Wanyenze, Julie A Denison, Olivier Koole, Eric van Praag, Barbara Castelnuovo, Fred Wabwire-Mangen, Gideon P Kwesigabo & Robert Colebunders. (2017) Persons living with HIV infection on antiretroviral therapy also consulting traditional healers: a study in three African countries. International Journal of STD & AIDS 28:10, pages 1018-1027.
Crossref
Tariro D. Chawana, Monica Gandhi, Kusum Nathoo, Bernard Ngara, Alexander Louie, Howard Horng, David Katzenstein, John Metcalfe & Charles F. B. Nhachi. (2017) Defining a Cutoff for Atazanavir in Hair Samples Associated With Virological Failure Among Adolescents Failing Second-Line Antiretroviral Treatment. JAIDS Journal of Acquired Immune Deficiency Syndromes 76:1, pages 55-59.
Crossref
Kasey Claborn, Mary Beth Miller, Ellen Meier & Sofia Carbone. (2017) Development of a Conceptual Etiological Model of Treatment Regimen Fatigue Among Patients Engaged in HIV Care: A Qualitative Study. Journal of the Association of Nurses in AIDS Care 28:4, pages 479-490.
Crossref
Amanda R. Mathew, Bryan W. Heckman, Ellen Meier & Matthew J. Carpenter. (2017) Development and initial validation of a cessation fatigue scale. Drug and Alcohol Dependence 176, pages 102-108.
Crossref
Ryan McNeil, Thomas Kerr, Bill Coleman, Lisa Maher, M. J. Milloy & Will Small. (2016) Antiretroviral Therapy Interruption Among HIV Postive People Who Use Drugs in a Setting with a Community-Wide HIV Treatment-as-Prevention Initiative. AIDS and Behavior 21:2, pages 402-409.
Crossref
Will Small, M. J. Milloy, Ryan McNeil, Lisa Maher & Thomas Kerr. (2016) Plasma HIV-1 RNA viral load rebound among people who inject drugs receiving antiretroviral therapy (ART) in a Canadian setting: an ethno-epidemiological study. AIDS Research and Therapy 13:1.
Crossref
Flavio A. Cadegiani & Claudio E. Kater. (2016) Adrenal fatigue does not exist: a systematic review. BMC Endocrine Disorders 16:1.
Crossref
Eric J. Dziuban & Emilia D. Rivadeneira. (2016) Universal Antiretroviral Treatment Eligibility for Children and Adolescents Living With HIV. Pediatric Infectious Disease Journal 35:11, pages 1225-1228.
Crossref
Monika Roy, Nancy Czaicki, Charles Holmes, Saurabh Chavan, Apollo Tsitsi, Thomas Odeny, Izukanji Sikazwe, Nancy Padian & Elvin Geng. (2016) Understanding Sustained Retention in HIV/AIDS Care and Treatment: a Synthetic Review. Current HIV/AIDS Reports 13:3, pages 177-185.
Crossref
Barbara Castelnuovo, Agnes Kiragga, Frank Mubiru, Andrew Kambugu, Moses Kamya & Steven J Reynolds. (2016) First-line antiretroviral therapy durability in a 10-year cohort of naïve adults started on treatment in Uganda. Journal of the International AIDS Society 19:1, pages 20773.
Crossref
Eida M. Castro, Lydia E. Santiago, Julio C. Jiménez, Daira Dávila-Vargas & Milagros C. Rosal. (2015) A Social-Ecological View of Barriers and Facilitators for HIV Treatment Adherence: Interviews with Puerto Rican HIV Patients. PLOS ONE 10:9, pages e0125582.
Crossref
Kasey R. Claborn, Mary Beth Miller & Ellen Meier. (2015) Initial Validation of the HIV Treatment Regimen Fatigue Scale for Adults Prescribed Antiretroviral Therapy. Journal of the Association of Nurses in AIDS Care 26:4, pages 308-315.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.